Doppel Farmaceutici

Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.

The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.

Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.

In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.

2001

The company acquired the Rozzano, Milan plant from Pfizer in 2001 providing specialised capabilities in oral solids and injectable dosage forms.

2003

In 2003, Doppel further enhanced its Research & Development capabilities at its Rozzano plant with the construction of new state-of-the-art laboratories for Pharmaceutical and Analytical Development.

2009 - 2011

Doppel expanded its alimentary manufacturing division in 2009 and constructed further pharmaceutical facilities at its Cortemaggiore site in 2011.

2020

Doppel  has acquired 90% of Dietopack, a leading Italian contract development and manufacturing organization (CDMO).